An Al­ler­gan psy­chi­atric drug failed late-stage de­pres­sion stud­ies — but Ab­b­Vie is go­ing for ap­proval any­way

Cariprazine, the Al­ler­gan-turned-Ab­b­Vie drug for bipo­lar de­pres­sion and schiz­o­phre­nia, had a rocky road through clin­i­cal tri­als be­fore its ap­provals. And as Ab­b­Vie at­tempts to fur­ther …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER